{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 443846387
| IUPAC_name = 4-chloro-''N''-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
| image = Glyclopyramide.svg

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| ATC_prefix = none
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 71793
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = KE474IKG1W
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01799
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2105083
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 631-27-6
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 64820

<!--Chemical data-->
| chemical_formula = 
| C=11 | H=14 | Cl=1 | N=3 | O=3 | S=1 
| molecular_weight = 303.76 g/mol
| smiles = C1CCN(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C11H14ClN3O3S/c12-9-3-5-10(6-4-9)19(17,18)14-11(16)13-15-7-1-2-8-15/h3-6H,1-2,7-8H2,(H2,13,14,16)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = HNSCCNJWTJUGNQ-UHFFFAOYSA-N

}}
'''Glyclopyramide''' ([[International Nonproprietary Name|INN]], marketed under the tradename '''Deamelin-S''') is a [[sulfonylurea]] drug used in the treatment of [[diabetes]]. It has been marketed in [[Japan]] since 1965.

It is classified as second generation.<ref name="pmid14570054">{{cite journal |vauthors=Ozawa H, Murai Y, Ozawa T |title=[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus] |language=Japanese |journal=Yakugaku Zasshi |volume=38 |issue=1 |pages=11–27 |year=2003 |pmid=14570054 |doi= |url=}}</ref>

==References==
<references/>

==External links==
* [http://www.kyorin-pharm.co.jp/prodinfo/medicine/pdf/DEAMELIN_S_Tablets.pdf DEAMELIN·S Tablets 250 mg]

{{Oral hypoglycemics}}
{{Ion channel modulators}}

[[Category:Potassium channel blockers]]
[[Category:Sulfonylureas]]
[[Category:Pyrrolidines]]
[[Category:Chloroarenes]]


{{gastrointestinal-drug-stub}}